⌘K

Login Start Free

Home/Filings/4/0001382963-18-000013

4//SEC Filing

Step Michael D 4

Accession 0001382963-18-000013

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 9:10 PM ET

Size

5.3 KB

Accession

0001382963-18-000013

Insider Transaction Report

Form 4

Period: 2018-01-23

RITTER PHARMACEUTICALS INCRTTR

DirectorCEO

Transactions

Award
Non-qualified Stock Option (Right to Buy)
2018-01-23+495,065→ 495,065 total
Exercise: $0.34Exp: 2028-01-23→ Common Stock (495,065 underlying)

Footnotes (1)

[F1]The option vests in forty-eight (48) equal monthly installments beginning on February 23, 2018 with the balance vesting on the 23rd day of each calendar month thereafter until vested in full.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

RITTER PHARMACEUTICALS INC

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001316386

Filing Metadata

Form type: 4
Filed: Jan 24, 7:00 PM ET
Accepted: Jan 25, 9:10 PM ET
Size: 5.3 KB

View on SEC.gov